David P. Ringer

1.3k total citations
58 papers, 1.1k citations indexed

About

David P. Ringer is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, David P. Ringer has authored 58 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 15 papers in Oncology and 14 papers in Pharmacology. Recurrent topics in David P. Ringer's work include Pharmacogenetics and Drug Metabolism (14 papers), RNA and protein synthesis mechanisms (11 papers) and DNA and Nucleic Acid Chemistry (10 papers). David P. Ringer is often cited by papers focused on Pharmacogenetics and Drug Metabolism (14 papers), RNA and protein synthesis mechanisms (11 papers) and DNA and Nucleic Acid Chemistry (10 papers). David P. Ringer collaborates with scholars based in United States, Netherlands and United Kingdom. David P. Ringer's co-authors include Stanislav Chládek, Donald E. Kizer, Charles Kiehlbauch, Rafael Álvarez-González, Frederick V. Schaefer, Myron K. Jacobson, Yoichi Sakakibara, Yasunari Takami, Masahito Suiko and Nasreen Aboul-Ela and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

David P. Ringer

58 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David P. Ringer United States 20 803 264 194 119 110 58 1.1k
Vandana Sridhar United States 16 742 0.9× 462 1.8× 505 2.6× 128 1.1× 122 1.1× 25 1.5k
N. Hirayama Japan 19 776 1.0× 100 0.4× 179 0.9× 78 0.7× 146 1.3× 81 1.4k
Shaun D. Black United States 17 917 1.1× 267 1.0× 521 2.7× 150 1.3× 50 0.5× 32 1.4k
Chang Kee Lim United Kingdom 21 637 0.8× 102 0.4× 191 1.0× 129 1.1× 87 0.8× 52 1.2k
Curtis A. Spilburg United States 22 673 0.8× 220 0.8× 42 0.2× 53 0.4× 135 1.2× 30 1.4k
L. H. Patterson United Kingdom 16 481 0.6× 157 0.6× 134 0.7× 60 0.5× 160 1.5× 31 925
Gustaf Söderlund Sweden 6 706 0.9× 258 1.0× 36 0.2× 79 0.7× 116 1.1× 7 1.2k
Jung-Ja P. Kim United States 10 758 0.9× 192 0.7× 408 2.1× 112 0.9× 23 0.2× 10 1.3k
Alexander D. Lewis United Kingdom 19 855 1.1× 289 1.1× 137 0.7× 21 0.2× 354 3.2× 25 1.4k
T. Briggs United States 16 652 0.8× 311 1.2× 39 0.2× 89 0.7× 81 0.7× 40 1.2k

Countries citing papers authored by David P. Ringer

Since Specialization
Citations

This map shows the geographic impact of David P. Ringer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David P. Ringer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David P. Ringer more than expected).

Fields of papers citing papers by David P. Ringer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David P. Ringer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David P. Ringer. The network helps show where David P. Ringer may publish in the future.

Co-authorship network of co-authors of David P. Ringer

This figure shows the co-authorship network connecting the top 25 collaborators of David P. Ringer. A scholar is included among the top collaborators of David P. Ringer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David P. Ringer. David P. Ringer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sakakibara, Yoichi, Ken Yanagisawa, David P. Ringer, et al.. (1998). Molecular Cloning, Expression, and Characterization of Novel Human SULT1C Sulfotransferases That Catalyze the Sulfonation ofN-Hydroxy-2-acetylaminofluorene. Journal of Biological Chemistry. 273(51). 33929–33935. 114 indexed citations
2.
3.
Ringer, David P., et al.. (1997). Alterations in epidermal growth factor binding to hepatic membranes following dietary exposure of rats to known hepatocarcinogens. Toxicology Letters. 91(1). 7–12. 2 indexed citations
4.
Malejka‐Giganti, Danuta, et al.. (1997). Aryl Sulfotransferase IV Deficiency in Rat Liver Carcinogenesis Initiated with Diethylnitrosamine and Promoted withN-2-Fluorenylacetamide or Its C-9-Oxidized Metabolites. Experimental and Molecular Pathology. 64(2). 63–77. 6 indexed citations
5.
Kong, Jin & David P. Ringer. (1996). Quantitative analysis of changes in cell proliferation and apoptosis during preneoplastic and neoplastic stages of hepatocarcinogenesis in rat. Cancer Letters. 105(2). 241–248. 18 indexed citations
6.
Kiehlbauch, Charles, et al.. (1995). Homodimeric and Heterodimeric Aryl Sulfotransferases Catalyze the Sulfuric Acid Esterification of N-Hydroxy-2-acetylaminofluorene. Journal of Biological Chemistry. 270(32). 18941–18947. 30 indexed citations
7.
8.
Ringer, David P., et al.. (1994). Molecular Approach to Rapid Assessment of p53 Tumor Suppressor Mutations in Esophageal Tumors from Stained Histological Slides. Diagnostic Molecular Pathology. 3(2). 132–141. 4 indexed citations
10.
Ringer, David P., et al.. (1994). Molecular mechanisms for the regulation of aryl sulfotransferase IV expression during 2-acetylaminofluorene-induced hepatocarcinogenesis in rat. Chemico-Biological Interactions. 92(1-3). 343–350. 3 indexed citations
11.
Lyn‐Cook, Beverly, et al.. (1994). Hypomethylation of the rat aryl sulfotransferase IV gene and amplification of a DNA sequence during multistage 2-acetylaminofluorene hepatocarcinogenesis. Chemico-Biological Interactions. 92(1-3). 363–370. 5 indexed citations
12.
Kiehlbauch, Charles, Stanley D. Kosanke, & David P. Ringer. (1993). Changes in levels of ADP-ribose polymers in rat liver during 2-acetylaminofluorene-induced hepatocarcinogenesis. Carcinogenesis. 14(7). 1435–1440. 5 indexed citations
13.
Gilissen, Ron, et al.. (1992). Sulfation of hydroxylamines and hydroxamic acids in liver cytosol from male and female rats and purified aryl sulfotransferase IV. Carcinogenesis. 13(10). 1699–1703. 13 indexed citations
14.
Birckbichler, Paul J., et al.. (1992). Characterization of a complementary DNA for rat liver aryl sulfotransferase IV and use in evaluating the hepatic gene transcript levels of rats at various stages of 2-acetylaminofluorene-induced hepatocarcinogenesis.. PubMed. 52(17). 4779–86. 37 indexed citations
15.
Ringer, David P., et al.. (1991). Alteration in de novo pyrimidine biosynthesis during uridine reversal of pyrazofurin‐inhibited dna synthesis. Journal of Biochemical Toxicology. 6(1). 19–27. 4 indexed citations
16.
Ringer, David P., et al.. (1990). Fluorescence of phosphotyrosine — Terbium(III) complexes. Biochemical and Biophysical Research Communications. 168(1). 267–273. 11 indexed citations
18.
Ringer, David P., et al.. (1987). Further characterization of the ability of hepatocarcinogens to lower rat liver aryl sulfotransferase activity. Carcinogenesis. 8(11). 1749–1752. 20 indexed citations
20.
Panzeter, Phyllis L., et al.. (1987). Evidence for nucleoside channeling in vivo: Deoxythymidine incorporation into rat liver dTTP and nuclear matrix DNA. Biochemical and Biophysical Research Communications. 149(1). 27–33. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026